Chitosan-based systems demonstrate tumor-suppressive potential by inhibiting Programmed Death-Ligand 1 (PD-L1) upregulation via AMP-activated protein kinase (AMPK) activation and Signal Transducer and Activator of Transcription 1 (STAT1) suppression [50]. Here, STAT1 is linked to neoplasm.